← Back to Search

Reactive Balance Training for Stroke

N/A
Waitlist Available
Led By Avril Mansfield, PhD
Research Sponsored by Toronto Rehabilitation Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to stand independently without upper-limb support for >30 seconds.
Able to tolerate at least 10 postural perturbations while wearing a safety harness.
Must not have
Contraindications to exercise testing, such as symptomatic aortic stenosis, complex life-threatening arrhythmias, unstable angina, or orthostatic blood pressure decrease of >20 mmHg with symptoms.
>2.1m tall and/or weighing >150kg (limits of the safety harness system).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months, 8 months, and 12 months post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the effects of reactive balance training (RBT) on aerobic capacity and strength in people with chronic stroke.

Who is the study for?
This trial is for community-dwelling adults who had a stroke more than 6 months ago, can stand without support for over 30 seconds, and handle multiple balance disturbances with a safety harness. It's not for those meeting current exercise guidelines, with lower limb amputations, severe cognitive issues, ongoing physiotherapy including aerobic or strength training, contraindications to exercise testing like unstable angina or significant arrhythmias, recent injuries that could worsen with exercise, previous perturbation training within the year, too tall/heavy for the harness system (>2.1m/150kg), other neurological conditions affecting balance like Parkinson's disease.
What is being tested?
The study compares 'Reactive Balance Training' (RBT) which may improve both aerobic capacity and strength due to its whole-body movements against traditional Aerobic and Strength Training (AST). The goal is to see if RBT can match AST in improving fitness components while also enhancing balance control and confidence better than AST among people who have had a stroke.
What are the potential side effects?
While specific side effects are not listed here as it’s an exercise-based intervention rather than medication-related one; participants might experience general fatigue or muscle soreness post-exercise. There could be risks of falls during exercises despite safety measures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can stand on my own for more than 30 seconds without using my arms for support.
Select...
I can handle sudden movements while secured in a safety harness.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have conditions that make exercise testing unsafe for me.
Select...
I am taller than 2.1 meters and/or weigh more than 150 kilograms.
Select...
I am currently in a physiotherapy program that includes exercises for my legs.
Select...
I have had an amputation of a part of my lower limb.
Select...
I have severe osteoporosis with a history of fractures.
Select...
I do not have severe high blood pressure or uncontrolled diabetes.
Select...
I have a condition like Parkinson's that affects my balance.
Select...
I have a health condition or injury that could worsen with exercise.
Select...
I have not had any major illness, injury, or surgery in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months, 8 months, and 12 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months, 8 months, and 12 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Aerobic capacity
Lower extremity strength
Secondary study objectives
Activities-specific Balance Confidence scale
Berg balance scale
Falls in daily life
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Reactive balance trainingExperimental Treatment1 Intervention
Group II: Aerobic and strength trainingActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Toronto Rehabilitation InstituteLead Sponsor
53 Previous Clinical Trials
5,966 Total Patients Enrolled
14 Trials studying Stroke
3,114 Patients Enrolled for Stroke
University of TorontoOTHER
718 Previous Clinical Trials
1,042,464 Total Patients Enrolled
23 Trials studying Stroke
4,376 Patients Enrolled for Stroke
Heart and Stroke Foundation of CanadaOTHER
130 Previous Clinical Trials
72,763 Total Patients Enrolled
24 Trials studying Stroke
2,158 Patients Enrolled for Stroke

Media Library

Aerobic and Strength Training (AST) Clinical Trial Eligibility Overview. Trial Name: NCT04042961 — N/A
Stroke Research Study Groups: Aerobic and strength training, Reactive balance training
Stroke Clinical Trial 2023: Aerobic and Strength Training (AST) Highlights & Side Effects. Trial Name: NCT04042961 — N/A
Aerobic and Strength Training (AST) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04042961 — N/A
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top